|
ARID4A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.075800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.772560E-01 |
| Normal-vs-Stage2 |
8.722200E-01 |
| Normal-vs-Stage3 |
1.661950E-02 |
| Normal-vs-Stage4 |
1.804410E-03 |
| Stage1-vs-Stage2 |
3.375200E-01 |
| Stage1-vs-Stage3 |
2.838100E-04 |
| Stage1-vs-Stage4 |
2.35379999999896E-05 |
| Stage2-vs-Stage3 |
2.238800E-01 |
| Stage2-vs-Stage4 |
7.617900E-02 |
| Stage3-vs-Stage4 |
3.475000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.555400E-01 |
| Normal-vs-AfricanAmerican |
3.950000E-01 |
| Normal-vs-Asian |
5.498400E-01 |
| Caucasian-vs-AfricanAmerican |
5.866800E-01 |
| Caucasian-vs-Asian |
4.714800E-01 |
| AfricanAmerican-vs-Asian |
3.636800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.093240E-01 |
| Normal-vs-Female |
3.716800E-01 |
| Male-vs-Female |
1.979690E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.939950E-01 |
| Normal-vs-Age(41-60Yrs) |
6.125800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.772360E-01 |
| Normal-vs-Age(81-100Yrs) |
4.050600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.127600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.606200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.573000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.030300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.326600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.546200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.183900E-03 |
| Normal-vs-Grade 2 |
5.512500E-02 |
| Normal-vs-Grade 3 |
3.489600E-02 |
| Normal-vs-Grade 4 |
3.46280000007582E-07 |
| Grade 1-vs-Grade 2 |
3.595600E-02 |
| Grade 1-vs-Grade 3 |
3.88690000000524E-05 |
| Grade 1-vs-Grade 4 |
3.83349996191384E-09 |
| Grade 2-vs-Grade 3 |
7.99880000000863E-05 |
| Grade 2-vs-Grade 4 |
1.00940034108987E-10 |
| Grade 3-vs-Grade 4 |
6.762800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.602600E-04 |
| Normal-vs-ccB subtype |
1.50830000000823E-06 |
| ccA subtype-vs-ccB subtype |
1.6251444634463E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.860800E-01 |
| Normal-vs-N1 |
1.379060E-04 |
| N0-vs-N1 |
1.302280E-03 |
|
|
